H<sub>2</sub>S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine
Lung cancer is a lethal disease with no truly efficient therapeutic management despite the progresses, and metabolic profiling can be a way of stratifying patients who may benefit from new therapies. The present study is dedicated to profiling cysteine metabolic pathways in NSCLC cell lines and tumo...
| 出版年: | Antioxidants |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2023-12-01
|
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2076-3921/13/1/51 |
